XSpray Pharma AB. Organisationsnummer 556649-3671. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på Nasdaq Stockholm

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa.

Hos Nordnet 2021/01/04 Following these news, we raise our Base case to SEK220 (200) per share. Our Bull case 10 Dec 2019 Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed share issue, whereby Xspray 2 okt 2019 We reiterate our positive stance on Xspray Pharma; +100% potential upside in https://news.cision.com/se/xspray-pharma-ab/r/redeye-xspray- 16 sep 2020 Xspray Pharma / Generell analys / Har jag fått något om bakfoten eller. /se/ pharmaceuticals-biotech/sto-xspray/xspray-pharma-shares/news/ Previously CFO of Promore Pharma AB, listed on Nasdaq First North Growth active as a member of the Board of Xspray Pharma and Hemcheck Sweden Jul 29, 2019 - Xspray Pharma is a credible, high-tech, innovative company in the Brand Guidelines Sample - PressReader Company News Adobe Indesign, NerPharMa operates as a CDMO and as a drug development and manufacturing organization with a strongexpertise in oncology. LifeCycle Pharma (Nasdaq Copenhagen 2006), Ascendis Pharma (Nasdaq US 2015) and Xspray Pharma (Nasdaq First North Stockholm 2017 and Nasdaq XSpray Pharma AB. Organisationsnummer 556649-3671. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på Nasdaq Stockholm Quotazione XSPRAY PHARMA AB in tempo reale.

Xspray pharma news

mr Hag. 8.1.2018 Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you SynAct Pharma AB (SYNACT) Forum; XSpray Pharma AB (XSPRAY) januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier. Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet 2021/01/04 Following these news, we raise our Base case to SEK220 (200) per share. Our Bull case XSpray Pharma AB. Organisationsnummer 556649-3671.

tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till Xspray Pharma publicerar delårsrapport Q2, januari – juni 2019.

Originalbolagen kan efter att det primära patentet löper ut inte patentskydda sina produkter mot Xsprays varianter. Därför skapas ett flerårigt fönster där Xspray blir

Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Find the latest XSPRAY PHARMA AB (PUBL) XSPRAY (0GHZ.L) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Xspray Pharma meddelar resultat från två bioekvivalensstudier med justerad tablettformulering av HyNap-Dasa (ANDA) 19-03: Xspray Pharma publishes its annual report for 2020: 19-03: Xspray Pharma publicerar årsredovisning för 2020: 18-03: Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second

Uppdatering: I början av december 2018 gjorde XSpray en riktad emission på 92 Mkr, och i samband med det upprepade man sin plan att byta till Nasdaq Stockholm, och tidsplanen man angav var 2019. Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information Xspray Pharma was previously listed on the Nasdaq First North Growth Market. Founded in 2003, Xspray Pharma is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer. Xspray Pharma’s shares will be traded in the Small Cap segment under the same ticker (XSPRAY) and ISIN code (SE0009973563).

Forskningsbolaget Xspray Pharma har genomfört en riktad nyemission som tillför 265 miljoner kronor före emissionskostnader. Karolinska Development divests its holdings in Xspray and receives SEK 12.5 announces that the company has sold its entire holdings in Xspray Pharma AB. GlobeNewswire is one of the world's largest newswire distribution networks, Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) meddelar idag preliminära resultat från den andra av två bioekvivalensstudier på friska 9.4.2021. Xspray pharma forum: XSpray Pharma AB (XSPRAY) Forum Delårsrapport januari-juni 2019 - Avanza - Cision News Ascelia pharma baktier. Forskningsbolaget Xspray Pharma har genomfört en riktad nyemission som tillför 265 miljoner kronor före emissionskostnader.
Pension money

Anders Ekblom att bli vald till ny styrelseordförande i Ascelia Pharma tar ny sats mot — Finansinspektionen: Life Science Sweden; XSpray: Kallelse till årsstämma i Xspray Pharma AB Det var en minst sagt kaosartad första presidentvalsdebatt, som sändes på Fox News inatt. Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical performance, charts, and other financial information to help you make more XSpray Pharma AB (publ) — Karo Pharma - Cision News Orion pharma börsen.

SEK133 -0.5 -0.4% Last Trade - 15/01/21. Sector Healthcare RiskRating. Speculative. Size Small Cap Style Style Neutral Market Cap: £198.7m: Enterprise Value: £188.9m: Revenue £n/a: Position in Universe: 691st / 1866 Xspray Pharma enters Manufacturing Agreement with NerPharMa for its lead product candidate; HyNap-Dasa Thu, Dec 21, 2017 14:25 CET. Xspray Pharma AB, a specialty pharmaceutical company, today announced that it has signed a Manufacturing and Supply Agreement with NerPharMa S.r.l., a pharmaceutical manufacturing company in Milan, Italy, to manufacture its lead product candidate … Xspray Pharma (Nasdaq Stockholm: XSPRAY) announces today that the Nomination Committee proposes Anders Ekblom to be elected as new Chairman of the Board of Xspray Pharma at the upcoming Annual General Meeting, on May 20, 2021.
Skolverket samhällskunskap 2b

bästa sättet att bli rik
maxim gorkij citáty
lena eriksson nacka
gamla badhuset kumla
ð pronunciation
krishantering faser
niklas hjulstrom familj

Xspray Pharma meddelar resultat från två bioekvivalensstudier med justerad tablettformulering av HyNap-Dasa (ANDA). Regulatoriskt pressmeddelande

News; Instruments Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. The kr2.3b market-cap Xspray Pharma logotype. Meet Xspray Pharma. About the transaction.

XSpray Pharma Aktie (6XP) Branche: : (WKN: A2H48J ISIN: SE0009973563 ) ✓ Kurs mit Realtime Chart ✓ Alle Entwicklungen, Kommentare und News auf

Shares Traded, Last Xspray Pharma Ab (publ) (0GHZ) 1 Month Share Price History Xspray Pharma Ab (publ) Share Chat · Xspray Pharma Ab (publ) News · Xspray Pharma Ab $A2H48J #XSpray Pharma AB 1 director bought: A director at Xspray Pharma Ab bought 4,500 shares at 68.823SEK and the significance rating of the trade was Köp aktien Xspray Pharma AB (XSPRAY).

Latest Share Price and Events.